HIV Post-Treatment Control: Insights On Remission from a Unique European Cohort

Asier Saez-Cirion, PhD
Head of Viral Reservoirs and Immune Control Unit
Institut Pasteur, Paris, France

CME VIDEOTop of page

How to Obtain CME Credit:Top of page

Click here to take the CME Evaluation and Post-Meeting Survey

About the Presenter:Top of page

Dr. Asier Sáez-Cirión received his PhD degree from the University of the Basque Country in Spain and did postdoctoral training at the FDA Center for Biologics Evaluation and Research in Bethesda. In 2003, he joined the Institut Pasteur where he is now Associate Professor and Head of the Viral Reservoirs and Immune Control Unit. Dr Sáez-Cirión is the Chair of the scientific and medical committee of Sidaction, a charity in France funding HIV research. He leads the VISCONTI study on Post-treatment HIV controllers and he is the coordinator of the ANRS RHIVIERA task force on HIV remission. His work is focused on understanding natural mechanisms associated with control of HIV/SIV infection and developing new therapeutic interventions to achieve HIV control in the absence of antiretroviral therapy.

Learning Objectives: Top of page

At the completion of this educational activity learners will:
1. Be aware of markers that may help predict who among people on ART may have better chances to control viremia if ART is discontinued for any reason.
2. Understand the viral and host factors that have been associated with post-treatment control, as well as the immune mechanisms mobilized during acute infection vs treatment interruption.
3. Know the difference between HIV remission and HIV cure.
4. Understand how post-treatment controllers are different (or are not) from other cases of durable remission or potential HIV cure.

CME Information:Top of page

This CME activity has approved for AMA PRA Category 1 Credit™ for December 13, 2023, as a live activity. This activity will also be available as an enduring activity from December 20, 2023, through December 12, 2026.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

Accreditation Statement:Top of page

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement:Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun (Course Director/Planner) has no relevant financial relationships to disclose.
- Dr. Joseph P. McGowan (Moderator) has no relevant financial relationships to disclose.
- Dr. Asier Sáez-Cirión (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Research grants from Merck, and ViiV; Honoraria from Merck, Gilead, and ViiV. Dr. Sáez-Cirión submitted his slides in advance for adequate peer review and supported his presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.

Financial Support:Top of page

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare

You must be logged in to post a comment. Login | Register